| 发明名称 |
USE OF NOBILETIN IN CANCER TREATMENT |
| 摘要 |
The present invention discloses a pharmaceutical composition of treating multidrug resistance cancer, comprising a citrus methoxyflavone and a chemotherapeutic drug, in which the citrus methoxyflavone is nobiletin. A method of treating multidrug resistance cancer comprising administrating citrus methoxyflavone and a chemotherapeutic drug is also disclosed. |
| 申请公布号 |
US2017027901(A1) |
申请公布日期 |
2017.02.02 |
| 申请号 |
US201514848358 |
申请日期 |
2015.09.09 |
| 申请人 |
Macau University of Science and Technology |
发明人 |
MA Wen-zhe;FENG Sen-ling;YAO Xiao-jun;YUAN Zhong-wen;LIU Liang;XIE Ying |
| 分类号 |
A61K31/353;A61K31/704;A61K31/337 |
主分类号 |
A61K31/353 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical composition for treating multidrug resistance cancer, comprising a citrus methoxyflavone and a chemotherapeutic drug. |
| 地址 |
Macau CN |
